Vincent Lisowski
Montpellier, 34093, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Enhancing brain delivery of tegaserod for Alzheimer's disease: a pharmaceutical comparison of two nanocarrier-based strategies.
Journal: International journal of pharmaceutics
Published: April 03, 2026
The Thienopyrimidinone Gamhépathiopine Targets the QO Site of Plasmodium falciparum Cytochrome b.
Journal: ACS infectious diseases
Published: June 03, 2025
Novel thienopyrimidones targeting hepatic and erythrocytic stages of Plasmodium parasites with increased microsomal stability.
Journal: European journal of medicinal chemistry
Published: July 03, 2023
New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability.
Journal: European journal of medicinal chemistry
Published: September 12, 2022
Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.
Journal: European journal of medicinal chemistry
Published: June 16, 2022
4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 08, 2022
Pd-catalyzed C-C and C-N cross-coupling reactions in 2-aminothieno[3,2-d]pyrimidin-4(3H)-one series for antiplasmodial pharmacomodulation.
Journal: RSC advances
Published: March 15, 2022
AAZTA-Derived Chelators for the Design of Innovative Radiopharmaceuticals with Theranostic Applications.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 20, 2022
Thienopyrimidine: A Promising Scaffold to Access Anti-Infective Agents.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 13, 2021
A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
Journal: Microbiology spectrum
Published: November 02, 2021
Active Targeted Nanoemulsions for Repurposing of Tegaserod in Alzheimer's Disease Treatment.
Journal: Pharmaceutics
Published: September 10, 2021
Implementation and validation of an in-house combined fluorescein/media-fill test to qualify radiopharmacy operators.
Journal: EJNMMI radiopharmacy and chemistry
Published: September 09, 2020
Last Updated: 09/26/2026